Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of...
Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial
About this item
Full title
Author / Creator
Lin, Yi , Raje, Noopur S. , Berdeja, Jesús G. , Siegel, David S. , Jagannath, Sundar , Madduri, Deepu , Liedtke, Michaela , Rosenblatt, Jacalyn , Maus, Marcela V. , Massaro, Monica , Petrocca, Fabio , Yeri, Ashish , Finney, Olivia , Caia, Andrea , Yang, Zhihong , Martin, Nathan , Campbell, Timothy B. , Rytlewski, Julie , Fuller, Jaymes , Hege, Kristen , Munshi, Nikhil C. and Kochenderfer, James N.
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
Idecabtagene vicleucel (ide-cel) is a B-cell-maturation antigen (BCMA)-directed chimeric antigen receptor T cell therapy. We performed a post hoc analysis of a single-arm phase 1 multicenter study in relapsed/refractory multiple myeloma (CRB-401) (
n
= 62; median follow-up, 18.1 months). The primary endpoint was safety outcomes, and secondar...
Alternative Titles
Full title
Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial
Authors, Artists and Contributors
Author / Creator
Raje, Noopur S.
Berdeja, Jesús G.
Siegel, David S.
Jagannath, Sundar
Madduri, Deepu
Liedtke, Michaela
Rosenblatt, Jacalyn
Maus, Marcela V.
Massaro, Monica
Petrocca, Fabio
Yeri, Ashish
Finney, Olivia
Caia, Andrea
Yang, Zhihong
Martin, Nathan
Campbell, Timothy B.
Rytlewski, Julie
Fuller, Jaymes
Hege, Kristen
Munshi, Nikhil C.
Kochenderfer, James N.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10504071
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10504071
Other Identifiers
ISSN
1078-8956,1546-170X
E-ISSN
1546-170X
DOI
10.1038/s41591-023-02496-0
